EHA 2016 | Answering the first question AML patients ask – how did I get this?
Mark Levis
• 9 Jun 2016
Mark Levis, MD, PhD from The Johns Hopkins University, Baltimore, MD discusses a common question that acute myeloid leukemia (AML) patients ask on their first visit, “how did I get this?”. Today there is a much better understanding of AML and often its cause cannot be pinpointed to a patient’s actions but rather is caused by the natural increase of mutations with age. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
